tiprankstipranks
Aprea Therapeutics Inc (APRE)
NASDAQ:APRE
US Market
APRE
Aprea Therapeutics
RESEARCH TOOLSreports
Want to see APRE full AI Analyst Report?

Aprea Therapeutics (APRE) Income Statement

502 Followers

Aprea Therapeutics Income Statement

Last quarter (Q4 2025), Aprea Therapeutics's total revenue was $3.34K, a decrease of -98.38% from the same quarter last year. In Q4, Aprea Therapeutics's net income was $-2.46M. See Aprea Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 285.76K$ 1.50M$ 583.23K$ 0.00$ 0.00
Gross Profit
$ 264.04K$ -7.86M$ 576.18K$ -16.40M$ -271.68K
Operating Expenses
$ 13.52M$ 6.46M$ 16.05M$ 96.99M$ 37.17M
Depreciation and Amortization
$ 21.71K$ 22.32K$ 7.05K$ 4.40K$ 271.68K
EBITDA
$ -13.23M$ -14.30M$ -14.28M$ -37.37M$ -36.86M
Operating Income
$ -13.23M$ -14.32M$ -15.47M$ -113.39M$ -37.45M
Other Income/Expenses
$ 634.27K$ 1.36M$ 1.19M$ 730.20K$ 319.05K
Pretax Income
$ -12.60M$ -12.96M$ -14.29M$ -112.66M$ -37.13M
Net Income
$ -12.60M$ -12.96M$ -14.29M$ -112.66M$ -36.54M
Per Share Metrics
Basic EPS
$ -1.93$ -2.35$ -3.95$ -1.36K$ -34.88
Diluted EPS
$ -1.93$ -2.35$ -3.95$ -1.36K$ -34.88
Weighted Average Shares Outstanding
 6.54M 5.51M 3.62M 82.85K 1.06M
Weighted Average Shares Outstanding (Diluted)
 6.54M 5.51M 3.62M 82.85K 1.06M
Currency in USD

Aprea Therapeutics Earnings and Revenue History